DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy

Clinical trial NCT06191614 · COMPLETED

Trial details

NCT number: NCT06191614
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetic Peripheral Neuropathy

Start date: 2022-05-19
Primary completion: 2023-06-30
Enrollment: 528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.